title: Inhibition of eosinophilic inflammation in allergen-challenged, IL-1 receptor type 1-deficient mice is associated with reduced eosinophil rolling and adhesion on vascular endothelium.
abstract: To determine the relative in vivo importance of IL-1 release after allergen challenge to the subsequent endothelial adhesion and recruitment of eosinophils, the authors used ovalbumin sensitization and inhalation challenge to induce airway eosinophilia in IL-1 receptor type 1-deficient and control wild-type mice. Bronchoalveolar lavage (BAL) eosinophil recruitment in IL-1 receptor type 1-deficient mice challenged with ovalbumin (24.3% +/- 6.3% BAL eosinophils) was significantly reduced compared with wild-type mice (63.7% +/- 2.5% BAL eosinophils). To determine whether the inhibition of eosinophil adhesion to vascular endothelium contributed to the inhibition of eosinophil recruitment in IL-1 receptor type 1-deficient mice, the authors used intravital microscopy to visualize the rolling and firm adhesion of fluorescence-labeled mouse eosinophils in the microvasculature of the allergen-challenged mouse mesentery. Eosinophil rolling, eosinophil firm adhesion to endothelium, and transmigration across endothelium (peritoneal eosinophils) were significantly inhibited in allergen-challenged IL-1 receptor type 1-deficient mice compared with wild-type mice. Overall, these studies demonstrate that cytokines such as IL-1, released after allergen challenge, are important in the induction of endothelial cell adhesiveness, a prerequisite for the recruitment of circulating eosinophils. (Blood. 2000;95:263-269)
authors.affiliation: Department of Medicine, University of California, San Diego, La Jolla 92093-0635, USA. dbroide@ucsd.edu
authors.forename: D H
authors.initials: DH
authors.lastname: Broide
authors.forename: K
authors.initials: K
authors.lastname: Campbell
authors.forename: T
authors.initials: T
authors.lastname: Gifford
authors.forename: P
authors.initials: P
authors.lastname: Sriramarao
mesh_terms: D000485:Allergens; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D002448:Cell Adhesion / Q000502:physiology*; D004730:Endothelium, Vascular / Q000276:immunology / Q000503:physiopathology*; D004804:Eosinophils / Q000276:immunology*; D005260:Female; D006969:Hypersensitivity, Immediate; D007249:Inflammation / Q000276:immunology*; D015848:Interleukin-5 / Q000235:genetics / Q000502:physiology*; D008168:Lung / Q000276:immunology / Q000502:physiology / Q000503:physiopathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D018345:Mice, Knockout; D008822:Mice, Transgenic; D011058:Pollen / Q000276:immunology*; D017472:Receptors, Interleukin-1 / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D012882:Skin Tests
chemical_list: D000485:Allergens; D015848:Interleukin-5; D017472:Receptors, Interleukin-1